                         SEQUENCE LISTING

<110>  IMMUNOVACCINE TECHNOLOGIES INC.
 
<120>  Pharmaceutical Compositions, Methods for Preparation 
       using Size Extrusion and Lipid Vesicle Particles, and 
       Uses Thereof

<130>  78961-200

<140>  PCT/CA2017/xxxxxx
<141>  2017-11-09

<160>  33    

<170>  PatentIn version 3.5


<210>  1
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Survivin HLA-A1 (modified)

<400>  1

Phe Thr Glu Leu Thr Leu Gly Glu Phe 
1               5                   


<210>  2
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Survivin HLA-A2 (modified)

<400>  2

Leu Met Leu Gly Glu Phe Leu Lys Leu 
1               5                   


<210>  3
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Survivin HLA-A24

<400>  3

Ser Thr Phe Lys Asn Trp Pro Phe Leu 
1               5                   


<210>  4
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Survivin HLA-B7

<400>  4

Leu Pro Pro Ala Trp Gln Pro Phe Leu 
1               5                   


<210>  5
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  A16Y T-helper epitope

<400>  5

Ala Gln Tyr Ile Lys Ala Asn Ser Lys Phe Ile Gly Ile Thr Glu Leu 
1               5                   10                  15      


<210>  6
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Survivin HLA-A3 (modified)

<400>  6

Arg Ile Ser Thr Phe Lys Asn Trp Pro Lys 
1               5                   10  


<210>  7
<211>  23
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  RSV SHeA

<400>  7

Asn Lys Leu Cys Glu Tyr Asn Val Phe His Asn Lys Thr Phe Glu Leu 
1               5                   10                  15      


Pro Arg Ala Arg Val Asn Thr 
            20              


<210>  8
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  RSV SHeB

<400>  8

Asn Lys Leu Ser Glu His Lys Thr Phe Cys Asn Lys Thr Leu Glu Gln 
1               5                   10                  15      


Gly Gln Met Tyr Gln Ile Asn Thr 
            20                  


<210>  9
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  HPV 16E7

<400>  9

Arg Ala His Tyr Asn Ile Val Thr Phe 
1               5                   


<210>  10
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  HPV Y9T

<400>  10

Tyr Met Leu Asn Leu Gly Pro Glu Thr 
1               5                   


<210>  11
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  HIV RGP10

<400>  11

Arg Gly Pro Gly Arg Ala Phe Val Thr Ile 
1               5                   10  


<210>  12
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  HIV AMQ9

<400>  12

Ala Met Gln Met Leu Lys Glu Thr Ile 
1               5                   


<210>  13
<211>  64
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  RSV Subtype A

<400>  13

Met Glu Asn Thr Ser Ile Thr Ile Glu Phe Ser Ser Lys Phe Trp Pro 
1               5                   10                  15      


Tyr Phe Thr Leu Ile His Met Ile Thr Thr Ile Ile Ser Leu Leu Ile 
            20                  25                  30          


Ile Ile Ser Ile Met Ile Ala Ile Leu Asn Lys Leu Cys Glu Tyr Asn 
        35                  40                  45              


Val Phe His Asn Lys Thr Phe Glu Leu Pro Arg Ala Arg Val Asn Thr 
    50                  55                  60                  


<210>  14
<211>  65
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  RSV Subtype B

<400>  14

Met Gly Asn Thr Ser Ile Thr Ile Glu Phe Thr Ser Lys Phe Trp Pro 
1               5                   10                  15      


Tyr Phe Thr Leu Ile His Met Ile Leu Thr Leu Ile Ser Leu Leu Ile 
            20                  25                  30          


Ile Ile Thr Ile Met Ile Ala Ile Leu Asn Lys Leu Ser Glu His Lys 
        35                  40                  45              


Thr Phe Cys Asn Lys Thr Leu Glu Gln Gly Gln Met Tyr Gln Ile Asn 
    50                  55                  60                  


Thr 
65  


<210>  15
<211>  23
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  RSV SHeA C45S

<400>  15

Asn Lys Leu Ser Glu Tyr Asn Val Phe His Asn Lys Thr Phe Glu Leu 
1               5                   10                  15      


Pro Arg Ala Arg Val Asn Thr 
            20              


<210>  16
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  RSV bSHeA

<400>  16

Asn Lys Leu Cys Asp Leu Asn Asp His His Thr Asn Ser Leu Asp Ile 
1               5                   10                  15      


Arg Thr Arg Leu Arg Asn Asp Thr Gln Leu Ile Thr Arg Ala His Glu 
            20                  25                  30          


Gly Ser Ile Asn Gln Ser Ser Asn 
        35                  40  


<210>  17
<211>  40
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  RSV bSHeA C45S

<400>  17

Asn Lys Leu Ser Asp Leu Asn Asp His His Thr Asn Ser Leu Asp Ile 
1               5                   10                  15      


Arg Thr Arg Leu Arg Asn Asp Thr Gln Leu Ile Thr Arg Ala His Glu 
            20                  25                  30          


Gly Ser Ile Asn Gln Ser Ser Asn 
        35                  40  


<210>  18
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  RSV SHeB C51S

<400>  18

Asn Lys Leu Ser Glu His Lys Thr Phe Ser Asn Lys Thr Leu Glu Gln 
1               5                   10                  15      


Gly Gln Met Tyr Gln Ile Asn Thr 
            20                  


<210>  19
<211>  24
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  RSV SHeB C45S

<400>  19

Asn Lys Leu Cys Glu His Lys Thr Phe Ser Asn Lys Thr Leu Glu Gln 
1               5                   10                  15      


Gly Gln Met Tyr Gln Ile Asn Thr 
            20                  


<210>  20
<211>  29
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  RSV L-SHeB C51S

<400>  20

Cys Gly Gly Gly Ser Asn Lys Leu Ser Glu His Lys Thr Phe Ser Asn 
1               5                   10                  15      


Lys Thr Leu Glu Gln Gly Gln Met Tyr Gln Ile Asn Thr 
            20                  25                  


<210>  21
<211>  429
<212>  DNA
<213>  Homo sapiens

<400>  21
atgggtgccc cgacgttgcc ccctgcctgg cagccctttc tcaaggacca ccgcatctct       60

acattcaaga actggccctt cttggagggc tgcgcctgca ccccggagcg gatggccgag      120

gctggcttca tccactgccc cactgagaac gagccagact tggcccagtg tttcttctgc      180

ttcaaggagc tggaaggctg ggagccagat gacgacccca tagaggaaca taaaaagcat      240

tcgtccggtt gcgctttcct ttctgtcaag aagcagtttg aagaattaac ccttggtgaa      300

tttttgaaac tggacagaga aagagccaag aacaaaattg caaaggaaac caacaataag      360

aagaaagaat ttgaggaaac tgcgaagaaa gtgcgccgtg ccatcgagca gctggctgcc      420

atggattga                                                              429


<210>  22
<211>  142
<212>  PRT
<213>  Homo sapiens

<400>  22

Met Gly Ala Pro Thr Leu Pro Pro Ala Trp Gln Pro Phe Leu Lys Asp 
1               5                   10                  15      


His Arg Ile Ser Thr Phe Lys Asn Trp Pro Phe Leu Glu Gly Cys Ala 
            20                  25                  30          


Cys Thr Pro Glu Arg Met Ala Glu Ala Gly Phe Ile His Cys Pro Thr 
        35                  40                  45              


Glu Asn Glu Pro Asp Leu Ala Gln Cys Phe Phe Cys Phe Lys Glu Leu 
    50                  55                  60                  


Glu Gly Trp Glu Pro Asp Asp Asp Pro Ile Glu Glu His Lys Lys His 
65                  70                  75                  80  


Ser Ser Gly Cys Ala Phe Leu Ser Val Lys Lys Gln Phe Glu Glu Leu 
                85                  90                  95      


Thr Leu Gly Glu Phe Leu Lys Leu Asp Arg Glu Arg Ala Lys Asn Lys 
            100                 105                 110         


Ile Ala Lys Glu Thr Asn Asn Lys Lys Lys Glu Phe Glu Glu Thr Ala 
        115                 120                 125             


Lys Lys Val Arg Arg Ala Ile Glu Gln Leu Ala Ala Met Asp 
    130                 135                 140         


<210>  23
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Survivin HLA-A1

<400>  23

Phe Glu Glu Leu Thr Leu Gly Glu Phe 
1               5                   


<210>  24
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Survivin HLA-A2

<400>  24

Leu Thr Leu Gly Glu Phe Leu Lys Leu 
1               5                   


<210>  25
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Survivin HLA-A3

<400>  25

Arg Ile Ser Thr Phe Lys Asn Trp Pro Phe 
1               5                   10  


<210>  26
<211>  27
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Mut25

<400>  26

Ser Thr Ala Asn Tyr Asn Thr Ser His Leu Asn Asn Asp Val Trp Gln 
1               5                   10                  15      


Ile Phe Glu Asn Pro Val Asp Trp Lys Glu Lys 
            20                  25          


<210>  27
<211>  27
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Mut30

<400>  27

Pro Ser Lys Pro Ser Phe Gln Glu Phe Val Asp Trp Glu Asn Val Ser 
1               5                   10                  15      


Pro Glu Leu Asn Ser Thr Asp Gln Pro Phe Leu 
            20                  25          


<210>  28
<211>  27
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Mut44

<400>  28

Glu Phe Lys His Ile Lys Ala Phe Asp Arg Thr Phe Ala Asn Asn Pro 
1               5                   10                  15      


Gly Pro Met Val Val Phe Ala Thr Pro Gly Met 
            20                  25          


<210>  29
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PADRE T-helper epitope


<220>
<221>  misc_feature
<222>  (3)..(3)
<223>  Xaa may be cyclohexylalanyl

<400>  29

Ala Lys Xaa Val Ala Ala Trp Thr Leu Lys Ala Ala Ala 
1               5                   10              


<210>  30
<211>  21
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  F21E T-helper epitope

<400>  30

Phe Asn Asn Phe Thr Val Ser Phe Trp Leu Arg Val Pro Lys Val Ser 
1               5                   10                  15      


Ala Ser His Leu Glu 
            20      


<210>  31
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  CpG oligonucleotide

<400>  31
tccatgacgt tcctgacgtt                                                   20


<210>  32
<211>  26
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  PolyI:C oligonucleotide (dIdC)


<220>
<221>  modified_base
<222>  (1)..(1)
<223>  Inosine

<220>
<221>  misc_feature
<222>  (1)..(1)
<223>  n is a, c, g, or t

<220>
<221>  modified_base
<222>  (3)..(3)
<223>  Inosine

<220>
<221>  misc_feature
<222>  (3)..(3)
<223>  n is a, c, g, or t

<220>
<221>  modified_base
<222>  (5)..(5)
<223>  Inosine

<220>
<221>  misc_feature
<222>  (5)..(5)
<223>  n is a, c, g, or t

<220>
<221>  modified_base
<222>  (7)..(7)
<223>  Inosine

<220>
<221>  misc_feature
<222>  (7)..(7)
<223>  n is a, c, g, or t

<220>
<221>  modified_base
<222>  (9)..(9)
<223>  Inosine

<220>
<221>  misc_feature
<222>  (9)..(9)
<223>  n is a, c, g, or t

<220>
<221>  modified_base
<222>  (11)..(11)
<223>  Inosine

<220>
<221>  misc_feature
<222>  (11)..(11)
<223>  n is a, c, g, or t

<220>
<221>  modified_base
<222>  (13)..(13)
<223>  Inosine

<220>
<221>  misc_feature
<222>  (13)..(13)
<223>  n is a, c, g, or t

<220>
<221>  modified_base
<222>  (15)..(15)
<223>  Inosine

<220>
<221>  misc_feature
<222>  (15)..(15)
<223>  n is a, c, g, or t

<220>
<221>  modified_base
<222>  (17)..(17)
<223>  Inosine

<220>
<221>  misc_feature
<222>  (17)..(17)
<223>  n is a, c, g, or t

<220>
<221>  modified_base
<222>  (19)..(19)
<223>  Inosine

<220>
<221>  misc_feature
<222>  (19)..(19)
<223>  n is a, c, g, or t

<220>
<221>  modified_base
<222>  (21)..(21)
<223>  Inosine

<220>
<221>  misc_feature
<222>  (21)..(21)
<223>  n is a, c, g, or t

<220>
<221>  modified_base
<222>  (23)..(23)
<223>  Inosine

<220>
<221>  misc_feature
<222>  (23)..(23)
<223>  n is a, c, g, or t

<220>
<221>  misc_feature
<222>  (25)..(25)
<223>  n is a, c, g, or t

<400>  32
ncncncncnc ncncncncnc ncncnc                                            26


<210>  33
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Palmitic Acid Adjuvant


<220>
<221>  misc_feature
<222>  (1)..(1)
<223>  Linked to PAM2 or PAM3

<400>  33

Cys Ser Lys Lys Lys Lys 
1               5

